SELLAS LIFE SCIENCES GROUP, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.35 USD | +5.47% |
|
-11.18% | +27.36% |
Chart calendar SELLAS Life Sciences Group, Inc.
01cc4563d1e7a314c25f.E2VuGatK7r3I17r-h2qmnDeiljf4gPH6i4aQacMXMdI.Xy5eW8AcitmyvOinqjrQ3V7y53Kwx6DN_szmBrdAQ7oqOhlA3Seo6vi6jg~643d52b65215ebc7d42b80500bd7f20b
Upcoming events on SELLAS Life Sciences Group, Inc.
Past events on SELLAS Life Sciences Group, Inc.
| 29/03/2024 01:35 am | Q4 2023 Earnings Release |
| 26/03/2024 05:45 pm | Business Update Call |
| 03/03/2024 04:30 pm | European School of Haematology Acute Leukaemias Conference - Abstract No:6192705 |
| 03/01/2024 07:00 pm | Business Update Call |
| 23/11/2023 05:30 pm | Annual General Meeting |
| 10/11/2023 02:34 am | Q3 2023 Earnings Release |
| 05/11/2023 | Global Meeting of the International Gynecologic Cancer Society |
| 27/09/2023 06:40 pm | Cantor Global Healthcare Conference |
| 11/08/2023 01:38 am | Q2 2023 Earnings Release |
| 21/06/2023 07:00 pm | Maxim Group Virtual Healthcare Conference - Fireside Chat |
| 20/06/2023 06:00 pm | Annual General Meeting |
| 05/06/2023 06:30 pm | American Society of Clinical Oncology Conference - Abstract No : TPS7074 |
| 30/05/2023 05:30 pm | Business Update Call |
| 12/05/2023 01:42 am | Q1 2023 Earnings Release |
| 17/03/2023 01:41 am | Q4 2022 Earnings Release |
| 31/01/2023 07:00 pm | Investor Meeting - Key Opinion Leader:Galinpepimut-S |
| 13/12/2022 | American Society of Hematology Meeting - Abstract #: 4263 |
| 12/12/2022 | American Society of Hematology Meeting - Abstract #: 3477 |
| 08/12/2022 01:50 am | JMP Securities Hematology Oncology Summit |
| 14/11/2022 07:00 pm | REGAL Phase 3 Clinical Trial Update Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 1,90 0,00 - | 7,60 5,07 50% | 1,00 1,00 0% | 0,00 13,0 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -17,2 -15,7 -9.7% | -17,0 -16,9 -0.39% | -25,3 -24,3 -4.19% | -42,0 -37,7 -11.17% | -37,9 -30,3 -24.83% | -38,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -19,4 -14,4 -34.79% | -16,8 -17,2 2.64% | -20,9 -23,4 10.57% | -41,3 -39,6 -4.25% | -37,3 -25,8 -44.54% | -40,0 |
|
Net income Million USD | Released Forecast Spread | -28,0 -19,4 -43.97% | -16,8 -17,3 2.41% | -20,7 -21,1 2.04% | -41,3 -39,6 -4.25% | -37,3 -29,8 -25.2% | -40,0 |
|
EPS USD | Released Forecast Spread | -10,9 -9,71 -12.52% | -2,11 -1,83 -15.3% | -1,34 -1,34 -0.19% | -2,13 -2,10 -1.55% | -1,34 -1,10 -21.82% | -1,14 |
| Announcement Date | 13/03/20 | 23/03/21 | 31/03/22 | 16/03/23 | 28/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 1,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 13,0 - | 0,00 13,0 - | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -11,6 -7,03 -65.32% | -6,74 -6,77 0.56% | -8,62 -7,39 -16.66% | -7,15 -8,00 10.71% | -9,45 -7,38 -27.96% | -11,3 -8,56 -31.86% | -8,84 -9,63 8.16% | -9,36 0,70 -1443.52% | -8,18 -0,64 -1168.4% | -10,0 | -10,2 | -10,4 | -10,6 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -6,84 -6,95 1.72% | -16,7 -6,22 -169.41% | -8,41 -7,27 -15.7% | -7,02 -8,00 12.26% | -9,12 -7,17 -27.29% | -11,1 -8,51 -30.36% | -8,84 -9,56 7.49% | -9,27 0,73 -1368.15% | -8,14 3,37 -341.39% | -9,95 | -9,96 | -10,2 | -10,5 |
|
Net income Million USD | Released Forecast Spread | -6,60 -6,95 5.12% | -16,7 -6,22 -169.41% | -8,41 -7,27 -15.7% | -7,02 -8,00 12.26% | -9,12 -7,17 -27.29% | -11,1 -8,51 -30.36% | -8,84 -9,56 7.49% | -9,27 0,73 -1368.15% | -8,14 3,37 -341.39% | -9,95 | -9,96 | -10,2 | -10,5 |
|
EPS USD | Released Forecast Spread | -0,42 -0,40 -4.13% | -1,05 -0,38 -176.32% | -0,41 -0,39 -5.13% | -0,34 -0,39 12.07% | -0,43 -0,32 -34.38% | -0,47 -0,29 -62.07% | -0,31 -0,36 12.68% | -0,33 0,02 -1985.71% | -0,25 -0,03 -837.38% | -0,25 | -0,20 | -0,20 | -0,19 |
| Announcement Date | 31/03/22 | 12/05/22 | 11/08/22 | 14/11/22 | 16/03/23 | 11/05/23 | 10/08/23 | 09/11/23 | 28/03/24 | - | - | - | - |
More events
Past sector events for SELLAS Life Sciences Group, Inc.
| 03/05/2024 01:35 am | KURA ONCOLOGY, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:35 am | ZYMEWORKS INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:32 am | ARDELYX, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:31 am | LONGBOARD PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:31 am | ASCENDIS PHARMA A/S: Q1 2024 Earnings Release |
| 03/05/2024 01:30 am | ULTRAGENYX PHARMACEUTICAL INC.: Q1 2024 Earnings Release |
| 02/05/2024 08:30 pm | GENMAB A/S: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | GERON CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | AGIOS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | BICYCLE THERAPEUTICS PLC: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SLS Stock
- Calendar SELLAS Life Sciences Group, Inc.
